Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ozonized vegetable oil + vitamin K2 + vitamin B9 is a combination nutraceutical and pharmaceutical mixture developed by S&R Farmaceutici spa. The formulation is primarily composed of ozonized vegetable oil, which generates ozonides and peroxides from unsaturated fatty acids to modulate oxidative stress and enhance antioxidant defenses. It is supplemented with vitamin K2 (menaquinone) and vitamin B9 (folic acid) to provide essential nutritional support and potentially synergize with the oil's metabolic effects. The mixture was evaluated in the ANTIOX001 pilot clinical trial (NCT05592509) to assess its antioxidant activity and impact on oxidative stress markers in moderately active individuals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ozonized vegetable oil + vitamin K2 + vitamin B9.